Selective serotonin reuptake inhibitor use and the risk of hepatocellular carcinoma
Crossref DOI link: https://doi.org/10.1007/s00228-022-03306-1
Published Online: 2022-05-17
Published Print: 2022-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lai, Shih-Wei http://orcid.org/0000-0002-7420-1572
Hwang, Bing-Fang
Liu, Chiu-Shong
Liao, Kuan-Fu
Text and Data Mining valid from 2022-05-17
Version of Record valid from 2022-05-17
Article History
Received: 1 February 2022
Accepted: 4 March 2022
First Online: 17 May 2022
Declarations
:
: The authors declare no competing interests.